CXHL1000615 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(3.4) | New Drug Application | 2011-02-16 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2012-05-17 | view |
CYHB1850047 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2018-05-15 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2018-07-24 | view |
CXHL1000616 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(3.4) | New Drug Application | 2011-02-16 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2012-05-17 | view |
CYHB1850218 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2018-09-25 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2021-02-05 | view |
CYHB1850048 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2018-05-15 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2018-07-24 | view |
CYHS0601022 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(6) | Generic Drug | 2006-03-22 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2009-01-04 | view |
CYHB1850217 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2018-09-25 | 齐鲁制药(海南)有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | Certificate Issued | 2021-02-05 | view |
JXHL0900407 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Import Drug Application | 2009-12-25 | 韩美药品株式会社 | Hanmi Pharm Co Ltd | Certificate Issued | 2010-12-09 | view |
JXHL0900408 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Import Drug Application | 2009-12-22 | 韩美药品株式会社 | Hanmi Pharm Co Ltd | Certificate Issued | 2010-12-09 | view |
CYHS1101687 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(6) | Generic Drug | 2013-02-25 | 辰欣药业股份有限公司 | Cisen Pharmaceutical Co Ltd | Certificate Issued | 2021-07-08 | view |
CYHS1101686 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(6) | Generic Drug | 2013-02-25 | 辰欣药业股份有限公司 | Cisen Pharmaceutical Co Ltd | Certificate Issued | 2021-07-08 | view |
JYHB1700726 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2017-05-23 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Filed | 2017-07-04 | view |
JYHB2001780 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2020-09-17 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-11-20 | view |
JYHB1900416 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-04-08 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2019-06-10 | view |
JYHB2002329 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(1) | Supplementary Application | 2020-11-18 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-02-09 | view |
JYHB1500140 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2015-02-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2015-12-10 | view |
JYHB1601412 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2016-10-25 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-04-19 | view |
JYHB1200978 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2012-09-28 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2013-05-13 | view |
JYHZ2000252 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | License Renew | 2020-11-18 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Completed-Pending Withdrawn | 2021-03-18 | view |
JYHB2000523 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2020-05-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-06-03 | view |